Skip to main content
OpenTrials
Completed

NCT Number: NCT01819168

Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

The aim of this retrospective study is to analyze if nighttime antimuscarincs may be more effective in treating patients with nocturia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–99 year

Sex eligibility

Female

Study type

Observational

Primary location

Far Eastern Memorial Hospital

Banqiao District, New Taipei, 22050, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients who underwent tolterodine SR treatment once per day for 12 weeks in Department of Obstetrics & Gynecology in National Taiwan University Hospital and Far Eastern Memorial Hospital

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. bladder diary

    Time frame: 3 months

    To clarity any difference of reduction in the episodes of nocturia between these two groups.

Secondary outcomes

  1. Frequency and Urgency

    Time frame: 3 months

    To clarity any difference of reduction in the episodes of urinary frequency and urgency between these two groups.

Sponsors and collaborators

Lead sponsor

Far Eastern Memorial Hospital

Other

Registry information

Important dates

Study start
2013
Primary completion
2015
Study completion
2016
First posted
Mar 27, 2013
Registry last updated
Sep 7, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.